Midatech Pharma plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTP research report →
Companywww.midatechpharma.com
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents.
- CEO
- Stephen A. Stamp
- IPO
- 2015
- Employees
- 20
- HQ
- Cardiff, GB
Price Chart
Valuation
- Market Cap
- $1.98M
- P/E
- -0.08
- P/S
- 0.00
- P/B
- 0.05
- EV/EBITDA
- 0.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -55.81%
- ROIC
- -72.30%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-5,729,000 · 19.07%
- EPS
- $-11.57 · -405.24%
- Op Income
- $-9,199,000
- FCF YoY
- -83.88%
Performance & Tape
- 52W High
- $20.80
- 52W Low
- $0.19
- 50D MA
- $1.50
- 200D MA
- $6.83
- Beta
- 1.22
- Avg Volume
- 1.84M
Get TickerSpark's AI analysis on MTP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 10, 11 | Kiley Quinn Thomas | buy | 1,000 |
| Oct 6, 10 | ZIMMERMAN GIFFORD R | other | 0 |
| Oct 6, 10 | TOTH TERENCE J | other | 0 |
| Oct 6, 10 | SCHNEIDER WILLIAM J | other | 0 |
| Oct 6, 10 | MARTIN LARRY W | other | 0 |
| Oct 6, 10 | LAMB DAVID J | other | 0 |
| Oct 6, 10 | EVANS JACK | other | 0 |
| Oct 6, 10 | Cook Margo L. | other | 0 |
| Oct 6, 10 | BREMNER ROBERT P | other | 0 |
| Oct 6, 10 | Antosiewicz Cedric H | other | 0 |
Our MTP Coverage
We haven't published any research on MTP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTP Report →